Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
33%
Adverse Event
48%
Analgesic Agent
15%
Antacid Agent
14%
Antibiotic Agent
19%
Antibiotics
19%
Anticoagulant Agent
13%
Anticonvulsive Agent
16%
Antidepressant
18%
Antiinfective Agent
24%
Asthma
16%
Bioavailability
14%
Bleeding
20%
Bursera
8%
Carcinoma
8%
Cefazolin
8%
Chronic Disease
13%
Cimetidine
9%
Ciprofloxacin
33%
Clinical Trial
35%
Cohort Study
34%
Combination Therapy
10%
Community Pharmacy
29%
Comorbidity
13%
Creatinine
8%
Cross-Sectional Study
13%
Dipeptidyl Carboxypeptidase Inhibitor
9%
Disease
88%
Doxorubicin
8%
Drug Information
11%
Drug Interaction
13%
Drug Utilization
11%
Drug-Drug Interaction
38%
Electronic Prescribing
14%
Elimination
18%
Envenomation
20%
Epileptic Absence
22%
Gabapentin
9%
Health Status
8%
Heart Failure
17%
Heart Infarction
12%
Hemodialysis
8%
Hemostatic Agent
8%
High Performance Liquid Chromatography
20%
Hospital Pharmacy
9%
Hydrogen Peroxide
9%
Infection
41%
Infectious Agent
13%
Injury
38%
Intubation
14%
Ketamine
12%
Levodopa-Induced Dyskinesia
12%
Major Depression
8%
Malignant Neoplasm
22%
Medication Error
30%
Metered-Dose Inhaler
33%
Microorganism
8%
Monotherapy
16%
Morphine
13%
Mouse
14%
Neoplasm
16%
Non Small Cell Lung Cancer
9%
Normal Human
23%
Observational Study
10%
Opiate
56%
Osimertinib
11%
Oxidizing Agent
7%
Oxycodone
7%
P-Glycoprotein
11%
Parkinson's Disease
19%
Perillyl Alcohol
8%
Pharmaceutical Care
27%
Pharmacodynamics
22%
Pharmacoeconomics
24%
Pharmacokinetics
77%
Pharmacotherapy
46%
Phencyclidine
10%
Phenytoin
8%
Phytochemical
9%
Placebo
11%
Poison Control Centers
12%
Prescription Drug
12%
Prevalence
23%
Randomized Controlled Trial
29%
Septic Shock
8%
Skin Cancer
8%
Snakebite
13%
Statin (Protein)
10%
Symptom
10%
Tablet
10%
Tapentadol
8%
Theophylline
10%
Therapeutic Drug Monitoring
9%
Toxic Injury
25%
Turmeric
16%
Vancomycin
8%
Venous Thromboembolism
13%
Volume of Distribution
13%
Warfarin
19%
Wound
7%
Medicine and Dentistry
ABC Transporter Subfamily B
10%
Adverse Drug Reaction
7%
Adverse Event
21%
Ambulatory Care
8%
Analgesia
9%
Anodyne
13%
Antibiotics
11%
Antidepressant
8%
Apoplexy
16%
Biopsy
7%
Bladder
23%
Bladder Carcinoma
14%
Bleeding
7%
Bone Metastasis
7%
Breast Cancer
13%
Carcinoma
12%
Cardiometabolic Risk
8%
Chronic Disease
8%
Clinical Trial
10%
Clinician
26%
Cohort Analysis
7%
Community-Acquired Pneumonia
8%
Consultation
13%
Cost-Effectiveness Analysis
17%
COVID-19
11%
Cross Sectional Study
16%
Decision Making
7%
Diabetes
17%
Diagnosis
19%
Diagnostic Accuracy
9%
Disease
23%
Disease Management
10%
Drug Interaction
15%
Drug Therapy
100%
Electronic Health Record
9%
Emergency Department
39%
Emergency Medicine
15%
Epileptic Absence
7%
Epileptic Seizure
23%
Epithelial Cell
8%
Flow Cytometry
13%
Health Care
30%
Health Care Cost
76%
Health Outcomes
14%
Health Status
20%
Heart Failure
7%
Hemostat
8%
In Vitro
8%
Infection
11%
Injury
26%
Intensive Care
12%
Intensive Care Unit
17%
Interprofessional Education
8%
Intoxication
10%
Intubation
17%
Ischemia
7%
Logistic Regression Analysis
16%
Malignant Neoplasm
36%
Maturity Onset Diabetes of the Young
7%
Medicare
32%
Medication Therapy Management Service
7%
Medicine
8%
Mental Health
11%
Meta-Analysis
16%
Microbiome
8%
Microscopy
13%
Neoplasm
36%
Obesity
8%
Observational Study
8%
Odds Ratio
21%
Opiate
38%
Ostomy
12%
Pain
6%
Parathyroid Hormone-Related Protein
13%
Parkinson's Disease
9%
Pathologist
26%
Patient Care
14%
Patient with Diabetes
11%
Patient-Reported Outcome
8%
Pediatrics
7%
Prescription Drug
11%
Prevalence
16%
Primary Health Care
7%
Quality Improvement
7%
Quality of Life
23%
Randomized Controlled Trial
27%
Rapid Sequence Intubation
12%
Sedative Agent
11%
Stress Ulcer
7%
Symptom
7%
Systematic Review
29%
Teledermatology
8%
Telehealth
31%
Telemedicine
34%
Telepathology
41%
Transitional Cell Carcinoma
8%
Triage
11%
Venous Thromboembolism
7%
Veterans Affairs
10%
Wound
9%
Keyphrases
Activity Coefficient
12%
Adjusted Odds Ratio
9%
Adverse Effects
9%
Adverse Events
8%
Albumin
10%
All of Us Research Program
8%
Antacids
12%
Antitumor Agents
12%
Arizona
25%
Asthma
10%
Cardiomyocytes
17%
Chronic Conditions
8%
Cimetidine
8%
Ciprofloxacin
23%
Clinical Outcomes
9%
Clinical Pharmacist
10%
Clinical Practice
10%
College of Pharmacy
12%
Comprehensive Medication Review
12%
Confidence Interval
25%
Cost-effectiveness
11%
Critically Ill
14%
Critically Ill Patients
17%
Disposition Kinetics
16%
Drug Interactions
17%
Drug Utilization Study
10%
Emergency Department
28%
Epilepsy
19%
Ethanol
10%
First-pass Success
10%
Functional Groups
10%
Gene Expression
10%
Group Activity
10%
Health Care Costs
14%
Health Outcomes
13%
Health Status
8%
Health-related Quality of Life
8%
Healthcare Expenditure
22%
Healthcare Professionals
13%
High Risk
8%
Hispanic
12%
Hydrogen Peroxide
13%
Intensive Care Unit
17%
Managed Care Organization
8%
Medicaid
10%
Medical Expenditure Panel Survey
12%
Medicare Beneficiaries
8%
Medication Errors
8%
Meta-analysis
24%
Metered Dose Inhaler
10%
Morphine
10%
No Significant Difference
8%
Obese Patients
14%
Obesity
10%
Odds Ratio
15%
Older Adults
18%
Opioids
12%
Organic Compounds
12%
Outcome-based Contracts
10%
Oxidative Stress
8%
Pain Management
10%
Parathyroid Hormone-related Protein (PTHrP)
10%
Parkinson's Disease
33%
Pharmaceutical Care
8%
Pharmacist
48%
Pharmacist Attitudes
14%
Pharmacist Intervention
11%
Pharmacokinetics
31%
Pharmacy
29%
Pharmacy School
9%
Pharmacy Students
20%
Prescription Drugs
11%
Pricing Method
10%
Propensity Score Analysis
8%
Quality of Life
8%
Randomized Controlled Trial
15%
Rapid Sequence Intubation
10%
Rasch Analysis
11%
Rat Bladder
10%
Red Cell Membrane
10%
Retrospective Analysis
8%
Retrospective Cohort Study
9%
Scoping Review
8%
Student Pharmacists
10%
Sucralfate
8%
Systematic Meta-analysis
13%
Telehealth
14%
Telemedicine
22%
Telemedicine Services
8%
Telepathology
8%
Temporal Lobe
8%
Theophylline
8%
Trauma Patients
13%
Tumor
12%
United States
63%
United States Adults
25%
Upper Tract Urothelial Carcinoma
10%
Urinary Bladder
11%
Virtual Pathology
8%
Virtual Slide
8%